This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2016-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2020
Title: Sylwia Huber: Innovator in Antibody Research
Introduction
Sylwia Huber is a prominent inventor based in Rheinfelden, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 5 patents to her name, her work is paving the way for advancements in medical research and treatment.
Latest Patents
Among her latest innovations are the anti-alpha-synuclein antibodies and methods of use. This invention provides anti-human alpha-synuclein antibodies and outlines methods for utilizing these antibodies effectively. Her research is crucial in understanding and potentially treating neurodegenerative diseases.
Career Highlights
Sylwia Huber is currently employed at Hoffmann-La Roche Inc., a leading company in the pharmaceutical and biotechnology industry. Her role involves extensive research and development, focusing on innovative solutions that address critical health challenges.
Collaborations
Throughout her career, Sylwia has collaborated with notable colleagues, including Klaus Kaluza and Olaf Mundigl. These partnerships have enhanced her research efforts and contributed to the success of her projects.
Conclusion
Sylwia Huber's work in antibody research exemplifies the impact of innovation in biotechnology. Her contributions are vital for the advancement of medical science and the development of new therapeutic approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile